Evidence map›Paper›PMID 31913038›Full record

ArticleJournal of medicinal chemistry2020

Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity.

Verrill M Norwood, Ariana C Brice-Tutt, Shainnel O Eans, Heather M Stacy, Guqin Shi, Ranjala Ratnayake, James R Rocca, Khalil A Abboud, Chenglong Li, Hendrik Luesch and 2 more

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Verrill M NorwoodDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Ariana C Brice-TuttDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Shainnel O EansDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Heather M StacyDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Guqin ShiDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Ranjala RatnayakeDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
James R RoccaDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Khalil A AbboudDepartment of Chemistry, University of Florida, Gainesville, Florida 32610, United States.
Chenglong LiDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Hendrik LueschDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.ORCID 0000-0002-4091-7492
Jay P McLaughlinDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Robert W HuigensDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.ORCID 0000-0003-3811-2721

Funding

Novel Targeted Anticancer Agents from Marine CyanobacteriaR01CA172310 · NCI · UNIVERSITY OF FLORIDA · PI HENDRIK LUESCH · 2013 to 2026
$5.8M
Acquisition of a Q Exactive HF Hybrid Quadrupole-OrbitrapS10OD021758 · OD · UNIVERSITY OF FLORIDA · PI BASSO, KARI B · 2017 to 2017
$600k
Development of Complex Natural Product Libraries and Multidimensional Anticancer Screening PlatformsR50CA211487 · NCI · UNIVERSITY OF FLORIDA · PI RATNAYAKE, RANJALA · 2016 to 2020
$440k
NCI NIH HHS R01 CA172310NCI NIH HHS R50 CA211487NIH HHS S10 OD021758
6 · The paper itself

Abstract

Innovative discovery strategies are essential to address the ongoing opioid epidemic in the United States. Misuse of prescription and illegal opioids (e.g., morphine, heroin) has led to major problems with addiction and overdose. We used vincamine, an indole alkaloid, as a synthetic starting point for dramatic structural alterations of its complex, fused ring system to synthesize 80 diverse compounds with intricate molecular architectures. A select series of vincamine-derived compounds were screened for both agonistic and antagonistic activities against a panel of 168 G protein-coupled receptor (GPCR) drug targets. Although vincamine was without an effect, the novel compound

Indexed as

AnimalsChemical EngineeringDrug-Seeking BehaviorInjections, IntraperitonealInjections, IntraventricularMaleMiceMice, Inbred C57BLMorphineOpioid-Related DisordersOrexin Receptor AntagonistsOrexin ReceptorsProtein Structure, SecondaryVincamineHcrtr2 protein, mouseMorphineOrexin Receptor AntagonistsOrexin ReceptorsVincamine

Identifiers

PMID31913038
PMCPMC7324933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.